CPC C12N 5/0068 (2013.01) [C12N 5/0018 (2013.01); C12N 5/0695 (2013.01); C12Q 1/02 (2013.01); G01N 33/5073 (2013.01); C12N 2500/50 (2013.01); C12N 2502/1352 (2013.01); C12N 2533/30 (2013.01); C12N 2535/00 (2013.01)] | 8 Claims |
1. A method of producing cancer stem cells from brain, lung or ovarian cancer tissue, comprising:
culturing a living cell population from said cancer tissue in the presence of a gel substance to obtain a living cell population containing brain, lung or ovarian cancer stem cells,
wherein said gel substance is a synthetic polymer gel that induces expression of osteopontin in cells present in the living cell population obtained from cancer tissue, and converts at least a portion of said cells contained in the living cell population in to cancer stem cells; and
said synthetic polymer gel is composed of poly(sodium p-styrene sulfonate) (PNaSS) gel, poly-N-(carboxymethyl-N,N-dimethyl-2-(methacryloyloxy) ethanaminium (PCDME) gel, polyampholyte (PA) gel, poly(2-acrylamido-2-methyl-1-propanesulfonic acid) (PAMPS) gel, poly(N,N′-dimethylacrylamide) (PDMA) gel, poly(acrylic acid) (PAAc) gel, or double network gel having an interpenetrating network structure of PAMPS gel and PDMA gel.
|